Science for health 2024
Very happy to be invited yesterday at MEDVIA’s and BioWin’s sold-out (!) #sfh2024 congress on AI, Data & Digitalisation and…
How to get a medtech startup on the rails.
Great article featering RheumaFinder and our CEO Nicolaas Fosselle: https://lnkd.in/egtYqcWv on how to get a medtech startup on the rails…
The role of artificial intelligence in radiology
Excellent and insightful article of our CSO Lennart Jans in Artsenkrant discussing the relevant purpose, added value and future of…
RheumaFinder Announces Investment by Novalis Biotech
Februari 2024 – RheumaFinder is excited to announce an investment from Belgium’s Novalis Biotech Acceleration Fund. This investment, executed as…
New offices at the Watt Factory in Ghent
New offices at the Watt Factory in Ghent The RheumaFinder team has moved to new offices at the Watt Factory…
RheumaFinder’s study on validating the diagnostic accuracy of AI detecting hallmark lesions gets published in European Radiology
Dr. Thomas Van Den Berghe’s recent study called “Neural network algorithm for detection of erosions and ankylosis on CT of…
Fund for Scientific Research in Rheumatology (FWRO/FRSR)
Fund for Scientific Research in Rheumatology (FWRO/FRSR) Prof. Dr. Lennart Jans of RheumaFinder has been named as a recipient from…
Interview by the leading online newspaper Medscape
Interview by the leading online newspaper Medscape Prof. Dr. Lennart Jans was interviewed by the leading online newspaper Medscape at…
Annual scientific meeting of the European Alliance of Associations for Rheumatology (EULAR) Copenhagen
At the annual scientific meeting of the European Alliance of Associations…
European Society of Musculoskeletal Radiology Young Researcher Grant 2022
Very grateful and proud to announce that our Chief Science Officer, Thomas Van Den Berghe…